SCLERAL FIXATION OF CARLEVALE INTRAOCULAR LENS

Abstract

Purpose: The mean change in best-corrected visual acuity (BCVA), intraocular pressure, and endothelial cell counts after intraocular lens (IOL) implantation and the incidence rate of postoperative complications were estimated by systematic review and meta-analysis to assess the surgical and refractive outcomes of the sutureless scleral fixation Carlevale IOL. Methods: A literature search was conducted using PubMed, Embase, and Scopus. The weighted mean difference (WMD) was used to present the mean change in BCVA, intraocular pressure, and endothelial cell count after IOL implantation, whereas a proportional meta-analysis was used to estimate the pooled incidence rate of postoperative complications. Results: In the meta-analysis of 13 studies involving 550 eyes, the pooled WMD of the mean change in BCVA showed a significant improvement in BCVA in patients who underwent Carlevale IOL implantation (WMD = 0.38, 95% confidence interval: 0.30–0.46, P < 0.001; heterogeneity [I2] = 52.02%). The subgroup analyses indicated that the mean change in BCVA was not significantly higher according to the last follow-up visit, with no statistically significant subgroup effect (P = 0.21) (WMD up to 6 months: 0.34, 95% confidence interval: 0.23–0.45, I2 = 58.32%, WMD up to 24 months: 0.42, 95% confidence interval: 0.34–0.51, I2 = 38.08%). In the meta-analysis of 16 studies involving 608 eyes, the pooled incidence rate of postoperative complications was equal to 0.22 (95% confidence interval: 0.13–0.32, I2 = 84.87, P ≤ 0.001). Conclusion: Carlevale IOL implantation represents a reliable method of restoring vision in eyes with missing capsular or zonular support.